Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of ICP-488 in Moderate to Severe Plaque Psoriasis
NCT06109818Phase 2Completed
- Sponsor
- InnoCare Pharma
- Start
- Jan 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of icp-488 in plaque psoriasis, sponsored by InnoCare Pharma. Started Jan 2024; status: completed.
02
Drugs
icp-488
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06109818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06109818.